Fucoidan / Slug Cancer Research Results

F, Fucoidan: Click to Expand ⟱
Features:
Fucoidan is found in brown algae. Extracted from the seaweed species Fucus vesiculosus, Cladosiphon okamuranus, Laminaria japonica and Undaria pinnatifida.
In oncology research, fucoidan is most consistently described as an immunomodulatory and anti-angiogenic compound with additional pro-apoptotic and anti-metastatic effects in preclinical models. Mechanistically, fucoidan has been reported to suppress NF-κB and PI3K/AKT signaling, reduce VEGF-mediated angiogenesis, inhibit tumor cell adhesion and invasion, and promote apoptosis through caspase activation and mitochondrial pathways. It may also enhance NK cell and macrophage activity, contributing to anti-tumor immune responses. Effects vary substantially depending on molecular weight, sulfation pattern, and source species. Human clinical data remain limited, and many anticancer claims are derived from in vitro and animal studies.


Cancer Pathway Table: Fucoidan

Rank Pathway / Axis Cancer / Tumor Context Normal Tissue Context TSF Primary Effect Notes / Interpretation
1 Immune activation (NK cells / macrophages) NK activity ↑; macrophage activation ↑ (reported) Immune surveillance support R, G Immunostimulatory One of the most consistent themes; fucoidan enhances innate immune responses in tumor-bearing animal models.
2 NF-κB inflammatory / survival signaling NF-κB ↓; cytokines ↓ (reported) Inflammatory tone modulation R, G Anti-inflammatory / anti-survival Suppression of NF-κB contributes to reduced tumor-promoting inflammation and survival signaling.
3 PI3K → AKT signaling PI3K/AKT ↓; proliferation ↓ (model-dependent) ↔ R, G Growth signaling suppression Reported in multiple cancer cell models; often secondary to upstream immune or redox modulation.
4 Intrinsic apoptosis (mitochondrial pathway) Caspases ↑; Bax ↑; Bcl-2 ↓ (reported) Minimal apoptosis in normal cells (dose-dependent) G Apoptotic induction Apoptosis frequently reported in vitro; magnitude depends on molecular weight and sulfation.
5 Angiogenesis (VEGF signaling) VEGF ↓; angiogenesis ↓ (reported) ↔ G Anti-angiogenic Anti-angiogenic activity is one of the more reproducible findings in preclinical systems.
6 Metastasis / adhesion (selectins, ECM interaction) Tumor adhesion ↓; invasion ↓ (reported) ↔ G Anti-metastatic Sulfated structure may interfere with selectin-mediated adhesion and tumor cell migration.
7 ROS / redox modulation ROS modulation (context-dependent) Antioxidant protection reported P, R Redox modulation (secondary) Fucoidan is not a primary pro-oxidant; redox effects appear secondary to signaling changes.
8 Chemo / radiation synergy Sensitization ↑ (reported in models) ↔ G Adjunct potential May enhance cytotoxic therapy response; evidence largely preclinical.
9 Warburg metabolism Indirect modulation (not a primary glycolysis inhibitor) ↔ R Metabolic secondary effect Metabolic changes likely downstream of survival pathway suppression rather than direct glycolysis blockade.
10 Bioavailability / heterogeneity constraint Effects vary by molecular weight and source Generally well tolerated orally — Translation constraint Composition varies widely by seaweed species and extraction method; standardization is critical.

TSF: P = 0–30 min (surface receptor interactions), R = 30 min–3 hr (immune and signaling shifts), G = >3 hr (apoptosis, angiogenesis, immune outcomes).



Slug, transcription factor Slug: Click to Expand ⟱
Source:
Type:
Slug is well known to promote tumor progression and metastasis through the epithelial-mesenchymal transition (EMT), causing loss of cell adhesion and polarity while conferring migratory and invasive properties.
Slug/SNAI2: A transcription factor that belongs to the Snail family. It is best known for its role in regulating epithelial-to-mesenchymal transition (EMT).
Expression: Upregulation of Slug in cancers is often associated with the induction of EMT. This causes cells to lose epithelial markers (like E-cadherin) and gain mesenchymal markers, leading to increased invasiveness.
Metastatic Spread: By promoting EMT, high levels of Slug facilitate tumor cell dissemination and metastasis.
Cancer Stem Cells: There is evidence suggesting that EMT, spurred by factors like Slug, can increase the proportion of cancer stem cells (CSCs). These CSCs are thought to be key players in tumor recurrence and maintenance.

General Trend: High Slug expression in various cancers (including breast, colorectal, head and neck, and others) is frequently correlated with a more aggressive phenotype and poorer clinical outcomes.
Scientific Papers found: Click to Expand⟱
1155- F,    The anti-cancer effects of fucoidan: a review of both in vivo and in vitro investigations
- Review, NA, NA
*toxicity↓, Casp3↑, Casp7↑, Casp8↑, Casp9↑, VEGF↓, angioG↓, PI3K↓, Akt↓, PARP↑, Bak↑, BID↑, Fas↑, Mcl-1↓, survivin↓, XIAP↓, ERK↓, EMT↓, EM↑, IM↓, Snail↓, Slug↓, Twist↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Mitochondria & Bioenergetics ⓘ

XIAP↓, 1,  

Cell Death ⓘ

Akt↓, 1,   Bak↑, 1,   BID↑, 1,   Casp3↑, 1,   Casp7↑, 1,   Casp8↑, 1,   Casp9↑, 1,   Fas↑, 1,   Mcl-1↓, 1,   survivin↓, 1,  

DNA Damage & Repair ⓘ

PARP↑, 1,  

Proliferation, Differentiation & Cell State ⓘ

EMT↓, 1,   ERK↓, 1,   PI3K↓, 1,  

Migration ⓘ

EM↑, 1,   Slug↓, 1,   Snail↓, 1,   Twist↓, 1,  

Angiogenesis & Vasculature ⓘ

angioG↓, 1,   VEGF↓, 1,  

Cellular Microenvironment ⓘ

IM↓, 1,  
Total Targets: 22

Pathway results for Effect on Normal Cells:


Functional Outcomes ⓘ

toxicity↓, 1,  
Total Targets: 1

Scientific Paper Hit Count for: Slug, transcription factor Slug
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:81  Target#:413  State#:%  Dir#:1
  wNotes=0  sortOrder:rid,rpid

 

Home Page